Skip to content

Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking

Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital and Constitution of a Biobank

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05532865
Acronym
SCLEROBREST
Enrollment
100
Registered
2022-09-08
Start date
2022-10-13
Completion date
2032-10-13
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Sclerosis

Keywords

Systemic Sclerosis, Patient library

Brief summary

This study corresponds to a monocentric prospective cohort of adult patients with systemic sclerosis. It will allow the constitution of an organized collection of longitudinal clinical data as well as collection of biological samples, including blood samples, as well as stool sample and skin swab for microbiota analysis.

Interventions

OTHERBlood samples

80 ml of blood samples collected at inclusion and at 18 months

OTHERStool samples

A stool sample for collection of digestive microbiota at inclusion

OTHERSkin swab samples

A skin swab sample for collection of skin microbiota at inclusion and at 18 months

OTHERQuestionnaires on quality of life, pain and disability

At inclusion and each year for 5 years

At inclusion and 18 months

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major patient with systemic sclerosis defined according to the EULAR 2013 criteria (see Appendix 1) * Patient evaluated within the framework of the reference center for rare autoimmune diseases of the CHU of Brest. * Patient affiliated to the social security system * Patient having signed a written informed consent.

Exclusion criteria

* Minor * Patient under legal protection (guardianship, curatorship) * Refusal to participate * Patient unable to consent * Pregnant or breastfeeding woman * Hemoglobin (Hb) level \< 7g/dl

Design outcomes

Primary

MeasureTime frameDescription
Age5 yearsTo assess whether age correlates with disease profile and progression
Sex5 yearsTo assess whether sex correlates with disease profile and progression
Weight5 yearsTo assess whether weight correlates with disease profile and progression
Medical history5 yearsTo assess whether medical history predicts the pattern and course of the disease
Family history5 yearsTo assess whether family history predicts the pattern and course of the disease
Rodnan score5 yearsThis score evaluates the thickness of the skin from 0 to 51. 0 meaning the absence of scleroderma (the healthiest score) and 51 completely sclerotic skin (the worst possible score)
active digital ulcers5 years4 characteristics must be taken into account: 1. the type of ulcer: mechanical/on calcinosis/ischemic 2. the recent/semi-recent/chronic character, 3. the painful character or not, 4. the total number of fingers affected on the 10 fingers.
dyspnea5 years* stage I: absence of dyspnea for usual efforts: no discomfort is felt in everyday life, * stage II: dyspnoea for usual heavy exertion, such as brisk or hill walking or climbing stairs (≥ 2 floors), * stage III: dyspnea for low intensity efforts of everyday life, such as walking on flat ground or climbing stairs (\< 2 floors), * stage IV: permanent dyspnea at rest or for minimal effort (putting on a garment, for example)
Free Carbon Monoxide Diffusion (DLCO)5 yearsFree Carbon Monoxide Diffusion (DLCO) in percentage.
6-minute walk test5 yearsDistance (in meters) covered in the 6-minute walk test.
systemic pulmonary arterial pressures5 yearsMeasured on cardiac ultrasound.

Secondary

MeasureTime frameDescription
SF-36 (Short-Form 36)5 yearsThe SF-36 is an indicator of health status and quality of life. The SF-36 has eight dimensions; the scores are weighted sums of the questions in each section. This scores range from 0 - 100. Lower scores indicate more disability and higher scores less disability. The eight dimensions of this score are: * Vitality * Physical functioning * Bodily pain * General health perceptions * Physical role functioning * Emotional role functioning * Social role functioning * Mental health
BPI : Pain scale5 yearsA quick and easy way to measure the intensity of pain and its impact on daily activities. Patients rate the maximum, minimum, average and current intensity of their pain and the influence of pain on seven aspects of functional ability. 3 scores are obtained between 0 and 10, with 10 corresponding to : * the worst pain experienced in the last 24 hours * the highest pain intensity combining the most intense, the least intense, the average pain and the pain experienced at the time of the questionnaire * the highest interference of the pain on daily activities
HAQ- Health Assessment Questionnaire - Disability Index5 yearsEvolution of HAQ-DI (Health Assessment Questionnaire - Disability Index) during follow-up 8 fields questionnaire (DRESSING \& GROOMING, ARISING, EATING, WALKING, HYGIENE, REACH, GRIP, Other activities), scaled from 0 to 3, 3 meaning a worse outcome

Countries

France

Contacts

CONTACTClaire DE MOREUIL
claire.demoreuil@chu-brest.fr0033298145303
CONTACTBénédicte ROUVIERE
benedicte.rouviere@chu-brest.fr0033298347345

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 27, 2026